BioNTech SE banner

BioNTech SE
NASDAQ:BNTX

Watchlist Manager
BioNTech SE Logo
BioNTech SE
NASDAQ:BNTX
Watchlist
Price: 92.885 USD 2.59%
Market Cap: $22.3B

Wall Street
Price Targets

BNTX Price Targets Summary
BioNTech SE

Wall Street analysts forecast BNTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BNTX is 140.765 USD with a low forecast of 82.931 USD and a high forecast of 190.05 USD.

Lowest
Price Target
82.931 USD
11% Downside
Average
Price Target
140.765 USD
52% Upside
Highest
Price Target
190.05 USD
105% Upside
BioNTech SE Competitors:
Price Targets
PWP
Perella Weinberg Partners
55% Upside
ANY
ANY Biztonsagi Nyomda Nyrt
-6% Downside
TCPC
BlackRock TCP Capital Corp
82% Upside
MRVL
Marvell Technology Group Ltd
28% Upside
MGIC
Magic Software Enterprises Ltd
6% Upside

Revenue
Forecast

56% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
56% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

For the last 7 years the compound annual growth rate for BioNTech SE's revenue is 56%. The projected CAGR for the next 3 years is 2%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BNTX's stock price target?
Price Target
140.765 USD

According to Wall Street analysts, the average 1-year price target for BNTX is 140.765 USD with a low forecast of 82.931 USD and a high forecast of 190.05 USD.

What is BioNTech SE's Revenue forecast?
Projected CAGR
2%

For the last 7 years the compound annual growth rate for BioNTech SE's revenue is 56%. The projected CAGR for the next 3 years is 2%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett